[F:1][C:2]1[CH:10]=[CH:9][CH:8]=[C:7]2[C:3]=1[CH2:4][CH2:5][N:6]2[C:11](=[O:21])[CH2:12][C:13]1[NH:18][C:17](=[O:19])[CH:16]=[C:15](Cl)[N:14]=1.[OH2:22]>CC1OCCNC1>[F:1][C:2]1[CH:10]=[CH:9][CH:8]=[C:7]2[C:3]=1[CH2:4][CH2:5][N:6]2[C:11](=[O:21])[CH2:12][C:13]1[NH:18][C:17](=[O:19])[CH:16]=[C:15]([N:6]2[CH2:7][CH2:8][O:22][CH:4]([CH3:3])[CH2:5]2)[N:14]=1A solution of 200 mg of 2-[2-(4-fluoro-2,3-dihydroindol-1-yl)-2-oxoethyl]-6-chloro-3H-pyrimidin-4-one in 2 ml of 2-methylmorpholine is heated at 100° C. for 15 minutes. The reaction medium is taken up with 10 ml of water. The solid formed is filtered off and washed with water and then dried so as to give 216 mg of 2-[2-(4-fluoro-2,3-dihydroindol-1-yl)-2-oxoethyl]-6-(2-methylmorpholin-4-yl)-3H-pyrimidin-4-one in the form of a beige solid, the characteristics of which are the following:
Wird geladen…